Follow the 에스티큐브 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 에스티큐브 has recorded 50 public disclosures. The latest transaction was reported on 25 February 2026 (Other). Among the most active insiders: 바이오메디칼홀딩스. Every trade is openly available.
50
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
15 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Estcube is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments and therapeutic solutions.